Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Continuous Estrogen Monitoring Patch

Project description

A wearable patch for continuous hormone monitoring

Oestrogen levels serve as indicators of reproductive health, cancer risk and mental health. Systematic monitoring of oestrogen is necessary for the management of infertility, hormone-dependent cancers and neurological conditions. However, current diagnostic methods require hospital visits and laboratory infrastructure, making regular monitoring impractical. With the support of the Marie Skłodowska-Curie Actions programme, the EstroPatch project aims to address these limitations through the development of a minimally invasive wearable sensor. The device utilises tiny microneedles to access fluid just beneath the skin for real-time oestrogen detection. By integrating microfluidics and wireless communication, the sensor is designed to facilitate continuous hormone monitoring for applications such as pregnancy tracking, menstrual cycle management and cancer treatment monitoring.

Objective

Estrogen monitoring is crucial across genders for tracking conditions like infertility (1 in 6 globally), breast/uterine cancers, postpartum depression, and schizophrenia. Endocrine cancers are rising in the EU (>100,000 neuroendocrine tumor cases, 60% at late stage), with endocrine-disrupting chemicals contributing significantly. Current estrogen monitoring methods are effective but invasive, hospital-based, and dependent on bulky instrumentation, making regular monitoring challenging. Therefore, there is a vital need to develop a highly sensitive, user-friendly wearable biosensing platform for continuous, on-site estrogen monitoring to ensure effective medical decision-making. Electrochemical biosensors offer high sensitivity and rapid response, making them ideal for wearable estrogen monitoring. Microneedle-based systems enable reliable, minimally invasive hormone detection through direct access to dermal interstitial fluid. This proposal aims to develop, for the first time, EstroPatch—a wearable patch for real-time, continuous monitoring of estrone, estradiol, and estriol levels in dermal interstitial fluid by integrating microneedles, electrochemical sensing, microfluidics, and wireless communication. This will address the current lack of microneedle-integrated systems for estrogen detection. In this project, I propose a multiplexed estrogen monitoring system spanning 0.1–5000 pg/mL using electrochemical sensing with optimized detection and quantitation limits. By integrating microneedles, I aim to develop EstroPatch as a pain-free, easy-to-use, and cost-effective solution for applications such as pregnancy monitoring, menstrual cycle tracking, and cancer treatment.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-GF - HORIZON TMA MSCA Postdoctoral Fellowships - Global Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

KATHOLIEKE UNIVERSITEIT LEUVEN
Net EU contribution
€ 321 301,44
Address
OUDE MARKT 13
3000 Leuven
Belgium
Region
Vlaams Gewest Prov. Vlaams-Brabant Arr. Leuven
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (1)